Roth David has filed 11 insider transactions across 1 company since March 2024.
Most recent transaction: a sale of 12099 shares of Syros Pharmaceuticals, Inc. ($SYRS) on November 18, 2024.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 18, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Roth David | Chief Medical Officer | S | Common Stock | 12099 | $0.20 | 0.0000 | 39,335,772 | 100.00% | 0.03% |
| Oct. 31, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Roth David | Chief Medical Officer | M | Common Stock | 18875 | $0.00 | 18,875.0000 | 39,335,772 | 9999.99% | 0.05% |
| Oct. 31, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Roth David | Chief Medical Officer | F | Common Stock | 6776 | $2.09 | 12,099.0000 | 39,335,772 | 35.90% | 0.02% |
| Oct. 31, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Roth David | Chief Medical Officer | M | Restricted Stock Units | 18875 | $0.00 | 0.0000 | 39,335,772 | 100.00% | 0.05% |
| April 3, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Roth David | Chief Medical Officer | S | Common Stock | 10451 | $4.95 | 0.0000 | 28,325,779 | 100.00% | 0.04% |
| March 31, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Roth David | Chief Medical Officer | M | Common Stock | 2000 | $0.00 | 2,000.0000 | 28,325,779 | 9999.99% | 0.01% |
| March 31, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Roth David | Chief Medical Officer | M | Common Stock | 13333 | $0.00 | 15,333.0000 | 28,325,779 | 666.65% | 0.05% |
| April 1, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Roth David | Chief Medical Officer | F | Common Stock | 4732 | $5.12 | 10,601.0000 | 28,325,779 | 30.86% | 0.02% |
| April 2, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Roth David | Chief Medical Officer | S | Common Stock | 150 | $4.98 | 10,451.0000 | 28,325,779 | 1.41% | 0.00% |
| March 31, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Roth David | Chief Medical Officer | M | Restricted Stock Units | 2000 | $0.00 | 4,000.0000 | 28,325,779 | 33.33% | 0.01% |
| March 31, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Roth David | Chief Medical Officer | M | Restricted Stock Units | 13333 | $0.00 | 26,667.0000 | 28,325,779 | 33.33% | 0.05% |